surmount 2 tirzepatide surmount-1 trial obesity without diabetes weight loss non-diabetic once weekly for the treatment of in people with type ( SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 SURMOUNT-1: Tirzepatide Drastically Tirzepatide after intensive lifestyle intervention
Pay in 4 interest-free payments of $6.13 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24









.webp?t=1743535811)












